Scarica l'app Stockscreener
136.95
0.77%
1.04
Dopo l'orario di chiusura:
136.95
Neurocrine Biosciences Inc Azioni (NBIX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
17.74%
959.00
|
814.50 | 805.50 | 794.90 | 687.50 |
| Selling, General, and Administrative |
38.05%
439.70
|
318.50 | - | - | - |
| Costs And Expenses |
30.01%
807.50
|
621.10 | 594.60 | 555.90 | 541.90 |
| Operating Income/Loss |
21.66%
151.50
|
193.40 | 210.90 | 239.00 | 145.60 |
| Nonoperating Income/Loss |
79.96%
10.70
|
53.40 | 28.50 | 52.80 | 13.90 |
| Income/Loss From Continuing Operations Before Tax |
34.28%
162.20
|
246.80 | 239.40 | 291.80 | 159.50 |
| Income Tax Expense/Benefit |
63.60%
17.80
|
48.90 | 85.70 | 82.30 | 52.00 |
Net Income/Loss
|
27.03%
144.40
|
197.90 | 153.70 | 209.50 | 107.50 |
| Basic Average Shares |
0.50%
101.00
|
100.50 | 0.20 | 99.40 | 99.00 |
| Diluted Average Shares |
0.77%
104.20
|
103.40 | 0.50 | 102.50 | 101.00 |
| Basic Earnings Per Share |
27.41%
1.43
|
1.97 | 1.54 | 2.11 | 1.09 |
| Diluted Earnings Per Share |
27.23%
1.39
|
1.91 | 1.48 | 2.04 | 1.06 |
4.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):